baber/WOPTO huggingface dataset:
Patent JP-H06104193-B2 (JP)
IPC: A61K9/48
Filed: 1986-12-26
Abstract: A soft capsule composed of a plurality of cells coalesced to each other and filling substances encapsulated in the individual cells, the wall of at least one of the cells being formed of a material different from a material forming the wall of at least one of the other cells, and said capsule being seamless. The soft capsule can be produced by   (a) preparing a plurality of composite jet streams each consisting of a stream of a film-forming liquid substance for forming a cell wall and within said stream of a film-forming liquid substance a single stream, or a plurality of independent streams, of a filling substance having flowability, the film-forming liquid subtance in at least one of the composite jet streams being different from the film-forming liquid substance in at least one of the other composite jet streams, (b) advancing the plurality of composite jet streams in closely spaced relationship into and through a stream of a liquid medium substantially incapable of dissolving the film-forming liquid substance in the flowing direction of the liquid medium stream, (c) coalescing the adjacent composite jet streams to each other to form a single composite jet stream in the liquid medium stream, (d) cutting the single composite jet stream to a predetermined length successively from its leading end in the liquid medium stream, and   (e) solidifying the cell walls of the resulting soft capsule.
Patent JP-4112712-B2 (JP)
IPC: H01M4/02
Filed: 1998-11-02
Granted: 2008-07-02
Abstract: PROBLEM TO BE SOLVED: To enhance ion conductivity, to improve the discharge characteristic, in particular, the rate characteristic and strength, to realize the formation of a thin film and to restrain the occurrence of a short circuit by containing polymer particles, and a polymer for bonding them and an electrolytic solution. SOLUTION: The weight ratio of polymer particles to a polymer for bonding the polymer particles is preferably 70:30 to 98:2. Preferably, polyvinylidene fluoride is used for the polymer particles, and a polymer containing a vinylidene fluoride unit, in particular, a hexafluoropropylene copolymer is used for the polymer. The average particle diameter of the polymer particles is preferably 0.1-0.5 μm. The polymer particles and the polymer having a swelling property with an electrolytic solution are suitable. In this solid electrolyte, its film thickness is preferably 5-100 μm. Preferably, its vacancy rate at the time of drying before impregnating the electrolytic solution is 35% or more and its fine hole diameter is 0.005-0.5 μm.
Patent JP-3725566-B2 (JP)
IPC: G10L15/28
Filed: 1993-12-28
Granted: 2005-12-14
Abstract: PURPOSE:To provide a voice recognition interface excellent in use convenience, capable of simultaneously handing plural application programs from a voice recognition system. CONSTITUTION:A voice recognition system 1 is connected to plural application programs 2. The system 1 controls the information relative to the programs 2 by an application program control table 13. Based on the information of the table 13, a message processing section 11 makes decisions on the recognition object vocabularies corresponding to the voice input, sending addresses of the recognition results at a voice identification section 12 which identifies the voice and the voice focus which specifies the object of the voice input to the plural application programs.
Patent JP-3467527-B2 (JP)
IPC: H01H1/04
Filed: 1992-12-17
Granted: 2003-11-17
Abstract: It is an object of the present invention to provide contact materials and manufacturing method of the same; said contact materials possess excellent characteristics in terms of contact resistance, corrosion resistance, bending strength, spring property, and ductility. On a band-shaped nickel-claded stainless steel substrate, there is either partially or entirely plated, at least one type of metal selected from noble metals, tin or tin-based alloys. Various evaluating tests including the contact resistance measurements, salt spray tests, sulfur dioxide tests, mixed gas tests of sulfur dioxide and sulfurized gas, and the bending strength tests are carried out on different samples and the results evaluated which showed that the present materials avoid anti-corrosion post-treatment after the press-forming process and exhibit excellent characteristics, particularly suitable to application for intermediate current and intermediate voltage regimes.
Patent JP-3781431-B2 (JP)
IPC: C08F210/16
Filed: 1996-06-18
Granted: 2006-05-31
Abstract: Catalysts for the polymerization of olefins comprise the product of the reaction between: (A) a titanium, zirconium or hafnium product with substituted cyclopentadiene ligands, (B) a mixture of two organometallic aluminium compounds, with at least one of the groups bound to the aluminium being other than a linear alkyl, and (C) water. When used in the polymerization of olefins, these catalysts show higher activities, at short residence times, than corresponding catalysts obtained from the individual components of the above-mentioned mixtures of aluminium compounds.
Patent JP-3248621-B2 (JP)
IPC: G01N33/86
Filed: 1996-06-06
Granted: 2002-01-21
Abstract: The present invention provides a method for determining thrombotic risk in an individual. The method involves determining the activity of Protein C and Protein S in the plasma of the individual thought to be at thrombotic risk by adding to a plasma sample obtained from the individual (i) a first reagent in an amount sufficient to induce or activate coagulation in the plasma, (ii) a second reagent which activates endogenous protein C in the plasma, and (iii) a third reagent comprising calcium salts, phospholipids or tissue thromboplastin, or a combination thereof. To a second plasma sample from the same subject is added a reagent which induces or activates coagulation, and a buffer or other material which does not activate protein C, and a third reagent as described above. The time, rate or both, necessary for the conversion of endogenous fibrinogen to fibrin in both the first and second samples is measured. The same steps are performed on normal control plasma, and the difference or ratio in the times, rates, or both, obtained above are determined. The difference or ratio is indicative of the thrombotic risk in the subject. A kit adapted to carry out the method also is the subject of the present invention. The methods and kits of the invention in other embodiments may comprise a first reagent comprising a synthetic substrate, a second reagent which in the first sample from the subject activates protein C, and in the second sample, a second reagent which does not activate protein C. In these embodiments, the rates of hydrolysis of the synthetic substrates are measured and compared.
Patent JP-H0637393-B2 (JP)
IPC: C07F9/22
Filed: 1986-12-04
Abstract: PCT No. PCT/EP86/00705 Sec. 371 Date Oct. 2, 1987 Sec. 102(e) Date Oct. 2, 1987 PCT Filed Dec. 4, 1986 PCT Pub. No. WO87/03480 PCT Pub. Date Jun. 18, 1987.Cytotoxically-effective medicaments containing hexadecylphosphocholine as active material.
Patent JP-3210016-B2 (JP)
IPC: B65H67/04
Filed: 1992-11-05
Granted: 2001-09-17
Abstract: PCT No. PCT/EP92/02539 Sec. 371 Date Jun. 17, 1994 Sec. 102(e) Date Jun. 17, 1994 PCT Filed Nov. 5, 1992 PCT Pub. No. WO93/09052 PCT Pub. Date May 13, 1993An automatic bobbin-changing device (10) for a winding machine with a vertical winding axis, the device having a bobbin carrier (12) which can rotate about a vertical axis (13) and which can adopt two bobbin-holding positions staggered at an angle of about 180 DEG . The bobbin carrier (12) has a total of four gripper arms (25, 26, 27, 28) which work together in pairs to grip a bobbin (1, 2). On each gripper arm (25, 26, 27, 28) is a bobbin-support surface (29) which, during the bobbin-changing operation, is positioned under the bobbin lower-flange (1b, 2b). The bobbin is changed by lifting the bobbin carrier (12) by means of a lifting mechanism (52, 54, 55) in such a way that the bobbin (1) on the winding machine is lifted off its mounting, the bobbin carrier (12) subsequently being rotated through 180 DEG  and lowered again.
Patent JP-3293629-B2 (JP)
IPC: C07J73/00
Filed: 1993-09-29
Granted: 2002-06-17
Abstract: A 7-substituted oxa- or azasteroid compound represented by general formula (I), which has an excellent aromatase-inhibiting effect and is useful for preventing or treating diseases caused by estrogens, such as breast cancer, uterine cancer and prostatomegaly. This compound has an oxygen or nitrogen atom as the heteroatom at the position A of the ring D and the 7-position (substituent R<1>) of the skeleton is substituted by -S-R<2> (wherein R<2> represents hydrogen, lower alkyl which may be substituted by hydroxy, amino or lower alkoxycarbonyl, lower alkenyl, aralkyl, aryl which may be substituted by halogen, amino, di(lower alkyl)amino, lower alkoxy or lower alkyl, acyl, or lower alkoxycarbonyl), - S(O)m-R<3> (wherein R<3> represents lower alkyl; and m represents 1 or 2), or aralkyl.
Patent JP-2941941-B2 (JP)
IPC: A61P25/08
Filed: 1990-06-18
Granted: 1999-08-30
Abstract: Radiation synovectomy compositions comprising a radionuclide complex selected from the group of 188-Re MAG3, 186-Re MAG3, 186-Re DADS, and 188-Re DADS bound to a substantially insoluble particle selected from the group of albumin microspheres, sulfur colloid, glass beads, albumin and latex.
Patent JP-3432519-B2 (JP)
IPC: C12N9/12
Filed: 1996-08-22
Granted: 2003-08-04
Abstract: Methods for enhancing the production of viral vaccines in animal cell culture are described. These methods rely on the manipulation of the cellular levels of certain interferon induced antiviral activities, in particular, cellular levels of double-stranded RNA (dsRNA) dependent kinase (PKR) and 2'-5' oligoadenylate synthetase (2-5A synthetase). In cell cultures deficient for PKR or 2-5A synthetase, viral yield is enhanced by several orders of magnitude over cell cultures with normal levels of these proteins making these cell cultures useful for the production of viral vaccines.
Patent JP-5041617-B2 (JP)
IPC: A23L29/00
Filed: 1997-10-23
Granted: 2012-10-03
Abstract: The present invention relates to an oral composition containing a zinc compound containing free available zinc ion and at least one stabilized or stable E<SUB>h </SUB>raising compound distributed in an oral vehicle. The present invention further relates to a method of inhibiting the formation of sulfur containing anions and preventing a reduction in the E<SUB>h </SUB>of the oral cavity. A method of reducing oral malodor and gingivitis and periodontitis is also provided by this invention.
Patent JP-4234206-B2 (JP)
IPC: A61K31/44
Filed: 1997-12-23
Granted: 2009-03-04
Abstract: PCT No. PCT/FR97/02395 Sec. 371 Date Jun. 22, 1999 Sec. 102(e) Date Jun. 22, 1999 PCT Filed Dec. 23, 1997 PCT Pub. No. WO98/28273 PCT Pub. Date Jul. 2, 1998The invention relates to a method for the preparation of 1-[2-(2-naphthyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine and its pharmaceutically acceptable salts by reacting 2-(2-bromoethyl)naphthalene with 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine or one of its salts, and to a universal method for the preparation of the same product and its salts by the reduction of naphthylacetic acid, treatment of the resulting 2-naphthylethanol with hydrobromic acid and treatment of the 2-(2-bromoethyl)naphthalene with 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine or one of its salts.
Patent JP-3746522-B2 (JP)
IPC: A23L7/157
Filed: 1997-03-05
Granted: 2006-02-15
Abstract: There is provided a substance which was isolated from the germinated seed of a grass family plant and which contains proteins and insoluble dietary fibers. There are also provided a pharmaceutical composition comprising as an active ingredient said substance which was isolated from the germinated seed of a grass family plant and which contains proteins and insoluble dietary fibers, and a food composition comprising said substance which was isolated from the germinated seed of a grass family plant and which contains proteins and insoluble dietary fibers, as well as uses of said substance.
Patent PL-76349-B2 (PL)
Title: Non-ageing, vacuum degassed, niobium-treated steel - steel[FR2081622A1]
IPC: C22C38/12
Filed: 1971-02-20
Abstract: Non-ageing steel contains (%) 0.0025-0.015 C, 0.02-0.3 Nb, 0.1-0.6 Mn, =0.035 S, =0.01 O2, =0.012 N, =0.045 Al. The Nb/C ratio is between 8:1 and 12:1, such taht all the Nb is present as NbC. The Mn/S ratio is 7:1 to reduce the number of harmful inclusions. N is stabilised either by Al or Ti prior to the addition of Nb to the melt. The steel has higher ductility and formability than current non-ageing steels, and is suitable for most deep drawing operations.
[FR2081622A1]
Patent ES-2351492-B2 (ES)
Title: Uso de la proteína rgs-14 para potenciar la memoria.
Inventor: ZAFARUDDIN KHAN
IPC: A61K38/17
Filed: 2009-05-28
Granted: 2011-09-15
Abstract: Uso de la proteína RGS-14 para
potenciar la memoria. 
     La administración de la proteína
RGS-14, también conocida como regulador de la
proteína-G señalizadora 14, en cerebro provoca un
incremento de la memoria en el reconocimiento de objetos en ratones.
Así, la proteína RGS-14 es útil para la fabricación
de un medicamento para el tratamiento terapéutico y/o preventivo de
desórdenes de la memoria en un mamífero así como de enfermedades
asociadas a estos desórdenes, tales como enfermedades neurológicas,
enfermedades neurodegenerativas, desórdenes del desarrollo o el
envejecimiento.
Patent ES-2638039-B2 (ES)
Title: Biopolímeros y proceso de obtención
Inventor: HITZL MARTIN
IPC: C10B53/02
Filed: 2017-02-08
Granted: 2018-11-29
Abstract: La presente invención pertenece al campo de la industria química, más concretamente al campo de la conversión de biomasa a un producto sólido polimérico con valor añadido. La invención proporciona un procedimiento para la obtención de biopolímeros en los que se ha sustituido al menos parcialmente la cantidad en peso correspondiente al fenol por un material residual renovable de coste menor Dicho procedimiento está caracterizado porque comprende una etapa de carbonización hidrotermal de biomasa lignocelulósica, y la adición posterior de una cantidad total de uno o más compuestos fenólicos y una cantidad total de aldehído, seguida del tratamiento térmico del producto obtenido.
Patent AU-2001284262-B2 (AU)
Title: Process and apparatus for recovering sulphur from a gas stream containing sulphide
Inventor: WATSON RICHARD WILLIAM
IPC: C01B17/04
Filed: 2001-09-04
Granted: 2006-10-12
Abstract: Oxygen or oxygen-enriched air is employed to support combustion in furnaces ( 16 ) and ( 26 ) of part of the hydrogen sulphide content of a first feed gas stream. Sulphur vapour is extracted in condenser ( 32 ) from the resulting gas mixture so as to form a sulphur vapour depleted gas stream. The sulphur vapour depleted gas stream is passed into a catalytic reduction reactor ( 40 ) in which all the residual sulphur dioxide is reduced to hydrogen sulphide. This reduced gas mixture has water vapour extracted therefrom in a quench tower ( 52 ). The resulting water vapour depleted gas stream flows to a Claus plant for treatment typically together with a second feed gas steam comprising hydrogen sulphide. Employing both furnaces ( 16 ) and ( 26 ) makes it possible to obtain effective conversions to sulphur of the hydrogen sulphide in the feed gas without having the recycle any of the water vapour depleted gas.
Patent AU-2002233182-B2 (AU)
Title: A process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
Inventor: FELUMB NIELS CHRISTIAN
IPC: A61K31/4525
Filed: 2002-03-01
Granted: 2004-10-14
Abstract: Pharmaceutical tablets containing crystalline paroxetine hydrochloride anhydrate are prepared using a process comprising an initial wet granulation process in which an aqueous granulation liquid is added to a mixture of said anhydrate an excipients under high-shear conditions and the thus obtained wet granules are dried using a fluidized bed technique to obtain a water activity within a specified range, after which the dried granules after addition of further adjuvants are compressed into stable tablets each having an identical composition.
Patent AU-2002234818-B2 (AU)
Title: Fuel tank vent valve and method of mounting
Inventor: BENJEY ROBERT PHILIP
IPC: F02M37/00
Filed: 2002-02-15
Granted: 2005-08-18
Abstract: A fuel vapor vent valve and method of making same for installation in an access opening of non-metallic fuel tanks. The valve body is formed of material not weldable to the tanks and an annular seal member formed of resilient material seals between the body upper portion exterior to the access opening and an overmold formed of material weldable to the tanks for retaining and sealing the valve thereon. In one embodiment the seal member is received in a groove and retained by a ring; and, in another embodiment the seal is formed by potting material cured in the groove prior to the overmolding.
Patent AU-2002246633-B2 (AU)
Title: Method of diagnosing and treating cartilage disorders
Inventor: WOOD WILLIAM I
IPC: A61P7/06
Filed: 2001-12-07
Granted: 2007-07-19
Abstract: The present invention is directed to novel polypeptides having sequence similarity to human inter-alpha-trypsin inhibitor and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods of using the polypeptide to diagnose and treat damage to cartilage resulting from injury and/or cartilaginous disorders.
Patent AU-2003244171-B2 (AU)
Title: Limb for Breathing Circuit
Inventor: GRAY NATHAN LEE
IPC: F16L11/115
Filed: 2003-09-02
Granted: 2007-11-15
Abstract: A limb for a breathing circuit manufactured from very thin walled polymer materials (40,44) has an elongate axial reinforcing spine (24) lying freely inside the conduit (25) and fixed to each end connector (23,49). The spine (24) is laterally compliant but axially stiff. The spine (24) provides resistance to tensile and compressive loads on the conduit (25), including that induced by prevailing internal pressures. <IMAGE>
Patent AU-2004210891-B2 (AU)
Title: Progenitor cells from Wharton's jelly of human umbilical cord
Inventor: DAVIES JOHN E
IPC: C12N5/077
Filed: 2004-02-10
Granted: 2008-09-25
Abstract: Human progenitor cells are extracted from Wharton's jelly that lies within a perivasculature zone of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours both osteoprogenitor cells and MHC-/- cells, and is useful to grow and repair human tissues including bone.
Patent AU-2005286109-B2 (AU)
Title: Sealed medical electrode package
Inventor: ALLEN JAMES
IPC: A61B5/0408
Filed: 2005-09-21
Granted: 2010-12-02
Abstract: A sealed medical electrode package comprises first and second electrodes each comprising a conductive layer (14) disposed on one major surface of a flexible nonconductive backing sheet (10). The electrodes are disposed with their conductive layers (14) face-to-face and their backing sheets separably sealed together around their peripheral edges so that the backing sheets form a substantially gas-impermeable enclosure containing the conductive layers. In an alternative embodiment (FIG. 6) a respective electrical contact extends through each backing sheet into electrical contact with the respective conductive layer, and a substantially gas-impermeable packaging material encloses the electrodes. The packaging material has a respective aperture exposing each electrical contact, the periphery of each aperture being sealed to the backing sheet around the respective contact.
Patent AU-2005304914-B2 (AU)
Title: Compositions and methods for stabilizing liposomal camptothecin formulations
Inventor: HOPE MICHAEL J
IPC: A61K31/47
Filed: 2005-11-04
Granted: 2012-02-16
Abstract: The present invention is directed to liposomal compositions comprising a camptothecin, which are optimized to reduce camptothecin degradation and/or precipitation of camptothecin degradation products in the external medium. The invention further provides improved methods of formulating liposomal camptothecins, kits comprising liposome-encapsulated camptothecins, and methods of using the same to treat a variety of diseases and disorders, including cancer.
Patent AU-2005308922-B2 (AU)
Title: Protein isolation and purification
Inventor: MARZABAL LUNA PABLO
IPC: C07K14/415
Filed: 2005-11-29
Granted: 2011-07-28
Abstract: A method for purifying a recombinant fusion protein that is expressed as recombinant protein body-like assemblies (RPBLAs) in host cells is disclosed in which an aqueous homogenate of transformed host cells that express a fusion protein as RPBLAs having a predetermined density is provided. Regions of different density are formed in the homogenate to provide a region that contains a relatively enhanced concentration of the RPBLAs and a region that contains a relatively depleted concentration of the RPBLAs. The RPBLAs-depleted region is separated from the region of relatively enhanced concentration of RPBLAs, thereby purifying said fusion protein. The region of relatively enhanced concentration of RPBLAs can thereafter be collected as desired.
Patent AU-2005314481-B2 (AU)
Title: Customer software for use with automatic verification of postal indicia products
Inventor: POULIN JEFFREY S
IPC: G07B17/00
Filed: 2005-11-22
Granted: 2011-07-07
Abstract: A method for verifying uniquely identifiable postal indicia in a closed loop system is provided. An embodiment of the method may include scanning a mail piece for human-readable and machine-readable images in a single image, including a postal indicium representing postage-related information associated with the mail piece, the postal indicium being uniquely identifiable and having human-readable and machine-readable portions. The method may further include sending information on the postal indicium to a point of automation for comparison against stored data on the postal indicium to determine whether the postal indicium is valid; receiving an instruction on how to handle the mail piece at the mail facility; and processing the mail piece in accordance with the received instructions.
Patent AU-2006232774-B2 (AU)
Title: Device for dosing and dry nebulization
Inventor: NOLTE OLIVER
IPC: B05B7/14
Filed: 2006-04-07
Granted: 2012-02-02
Abstract: The invention relates to a device (1) for dosing and dry nebulization of nebulizable material (12) chosen from the group comprising anti-infective agents and immunomodulators, comprising a nebulization channel (3) , which has a first attachment piece and a second attachment piece, and a source of compressed carrier gas connected to the first attachment piece via a valve (16) for the purpose of sending a carrier gas pressure pulse into the nebulization channel. The device is characterized in that between the first attachment piece and second attachment piece, and above the nebulization channel, a reservoir (10) open only towards the nebulization channel, which contains the nebulizable material (12), is connected to the nebulizaton channel such that it is gas-tight with respect to the environment, and that, when the valve is closed, a pressure compensation (22) takes place in the nebulization channel and in the reservoir. The invention also relates to a method for dosing and dry nebulization of such a nebulizable material by means of such a device.